Condition

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Amgen (1)

Collaborator

Amgen Astellas Biopharma K.K. (1)

Intervention

blinatumomab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

relapsed refractory b precursor acute lymphoblastic leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)

Completed

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia

Blinatumomab

Nagoya-shi, Aichi, Japan
+15 more

Dec 8, 2022